Cargando…
An edible vaccine development for coronavirus disease 2019: the concept
A novel coronavirus was emerged in December 2019 from Wuhan city, China and has now become a global threat to human health. Currently, the coronavirus disease 2019 (COVID-19) has spread to more than 34 countries with 2,445 deaths and 78,811 confirmed cases. Currently, there is no vaccine available a...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445323/ https://www.ncbi.nlm.nih.gov/pubmed/32864373 http://dx.doi.org/10.7774/cevr.2020.9.2.164 |
_version_ | 1783573966932148224 |
---|---|
author | Sohrab, Sayed Sartaj |
author_facet | Sohrab, Sayed Sartaj |
author_sort | Sohrab, Sayed Sartaj |
collection | PubMed |
description | A novel coronavirus was emerged in December 2019 from Wuhan city, China and has now become a global threat to human health. Currently, the coronavirus disease 2019 (COVID-19) has spread to more than 34 countries with 2,445 deaths and 78,811 confirmed cases. Currently, there is no vaccine available against COVID-19. The traditional vaccines development requires more time and high cost and due to this, the disease outbreaks becomes more challenging. Now a days, plants have become more attractive platform for edible vaccine production than the other system. The development of an edible vaccine in a selected plant system has many significant advantages such as; easy and efficient oral delivery, low cost with higher scale production, avoidance of any trained medical personnel for delivery, lack of any pathogenic infection, multicomponent expression in a single plant, and so forth. In this manuscript, the concept, development, and importance of an edible vaccine have been discussed. By using this plant-based platform, an edible vaccines can be produced in many crops like banana, cucumber, carrot, lettuce, and tomato against various diseases. Due to increasing cases globally with COVID-19, there is an urgent requirement to develop an ideal vaccine and antiviral therapy against this virus to control the disease worldwide. |
format | Online Article Text |
id | pubmed-7445323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Korean Vaccine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-74453232020-08-27 An edible vaccine development for coronavirus disease 2019: the concept Sohrab, Sayed Sartaj Clin Exp Vaccine Res COVID-19 Special A novel coronavirus was emerged in December 2019 from Wuhan city, China and has now become a global threat to human health. Currently, the coronavirus disease 2019 (COVID-19) has spread to more than 34 countries with 2,445 deaths and 78,811 confirmed cases. Currently, there is no vaccine available against COVID-19. The traditional vaccines development requires more time and high cost and due to this, the disease outbreaks becomes more challenging. Now a days, plants have become more attractive platform for edible vaccine production than the other system. The development of an edible vaccine in a selected plant system has many significant advantages such as; easy and efficient oral delivery, low cost with higher scale production, avoidance of any trained medical personnel for delivery, lack of any pathogenic infection, multicomponent expression in a single plant, and so forth. In this manuscript, the concept, development, and importance of an edible vaccine have been discussed. By using this plant-based platform, an edible vaccines can be produced in many crops like banana, cucumber, carrot, lettuce, and tomato against various diseases. Due to increasing cases globally with COVID-19, there is an urgent requirement to develop an ideal vaccine and antiviral therapy against this virus to control the disease worldwide. The Korean Vaccine Society 2020-07 2020-07-31 /pmc/articles/PMC7445323/ /pubmed/32864373 http://dx.doi.org/10.7774/cevr.2020.9.2.164 Text en © Korean Vaccine Society. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | COVID-19 Special Sohrab, Sayed Sartaj An edible vaccine development for coronavirus disease 2019: the concept |
title | An edible vaccine development for coronavirus disease 2019: the concept |
title_full | An edible vaccine development for coronavirus disease 2019: the concept |
title_fullStr | An edible vaccine development for coronavirus disease 2019: the concept |
title_full_unstemmed | An edible vaccine development for coronavirus disease 2019: the concept |
title_short | An edible vaccine development for coronavirus disease 2019: the concept |
title_sort | edible vaccine development for coronavirus disease 2019: the concept |
topic | COVID-19 Special |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445323/ https://www.ncbi.nlm.nih.gov/pubmed/32864373 http://dx.doi.org/10.7774/cevr.2020.9.2.164 |
work_keys_str_mv | AT sohrabsayedsartaj anediblevaccinedevelopmentforcoronavirusdisease2019theconcept AT sohrabsayedsartaj ediblevaccinedevelopmentforcoronavirusdisease2019theconcept |